JU, T., M, K., DA, B., S, G., H, M., J, L., . . . JB, K. (2015). Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival. Cancer, 121(5), 697. https://doi.org/10.1002/cncr.29090
Chicago Style (17th ed.) CitationJU, Tilan, et al. "Systemic Levels of Neuropeptide Y and Dipeptidyl Peptidase Activity in Patients with Ewing Sarcoma--associations with Tumor Phenotype and Survival." Cancer 121, no. 5 (2015): 697. https://doi.org/10.1002/cncr.29090.
MLA (9th ed.) CitationJU, Tilan, et al. "Systemic Levels of Neuropeptide Y and Dipeptidyl Peptidase Activity in Patients with Ewing Sarcoma--associations with Tumor Phenotype and Survival." Cancer, vol. 121, no. 5, 2015, p. 697, https://doi.org/10.1002/cncr.29090.